In December 2020, the Food and Drug Administration (FDA) issued emergency use authorizations (EUAs) for two vaccines against COVID-19 — one produced by Pfizer and BioNTechTrusted Source, and one by ModernaTrusted Source.
Now the FDA is reviewing another EUA request for a vaccine developed by Johnson & Johnson’s subsidiary company, Janssen Biotech.
